Literature DB >> 6581355

Nipple aspirate cytology for the study of breast cancer precursors.

E B King, K L Chew, N L Petrakis, V L Ernster.   

Abstract

The association of abnormal nonmalignant cells in nipple aspirate fluid (NAF) and atypical proliferative disease (APD) of breast ducts was examined in the presence and absence of breast cancer in 134 patients. A high frequency of NAF samples with cellular abnormalities (atypical hyperplasia) was found when APD occurred with either breast cancer (70%) or benign breast biopsy specimens (54%). APD was present in 27 malignant cases (80%) and in 39 benign cases (39%). Inasmuch as APD may represent an intermediate step in the malignant transformation of duct epithelium, the cytologic examination of NAF offers a new approach with which to study the spectrum of breast cancer precursors and to assist in identifying women at risk for breast cancer.

Entities:  

Mesh:

Year:  1983        PMID: 6581355

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  24 in total

Review 1.  Clinical applications of proteomics: proteomic pattern diagnostics.

Authors:  Emanuel E Petricoin; Cloud P Paweletz; Lance A Liotta
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-10       Impact factor: 2.673

2.  Cerumen phenotype and proliferative epithelium in breast fluids of U.S.-born vs. immigrant Asian women: a possible genetic-environmental interaction.

Authors:  N L Petrakis; E B King; M Lee; R Miike
Journal:  Breast Cancer Res Treat       Date:  1990-10       Impact factor: 4.872

Review 3.  Rating the risk factors for breast cancer.

Authors:  S Eva Singletary
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

4.  Potential for cytologic breast fluid analysis in breast disease.

Authors:  S H Dairkee; A J Hackett
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

Review 5.  Physiologic, biochemical, and cytologic aspects of nipple aspirate fluid.

Authors:  N L Petrakis
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

6.  Bowel function and breast cancer in US women.

Authors:  M S Micozzi; C L Carter; D Albanes; P R Taylor; L M Licitra
Journal:  Am J Public Health       Date:  1989-01       Impact factor: 9.308

Review 7.  Factors associated with obtaining nipple aspirate fluid: analysis of 1428 women and literature review.

Authors:  M R Wrensch; N L Petrakis; L D Gruenke; V L Ernster; R Miike; E B King; W W Hauck
Journal:  Breast Cancer Res Treat       Date:  1990-01       Impact factor: 4.872

8.  Biologic markers of breast cancer in nipple aspirate fluid and nipple discharge are associated with clinical findings.

Authors:  Edward R Sauter; Colette Wagner-Mann; Hormoz Ehya; Andres Klein-Szanto
Journal:  Cancer Detect Prev       Date:  2007-02-20

9.  Hormonal determinants of nipple aspirate fluid yield among breast cancer cases and screening controls.

Authors:  Angela J Fought; Claire McGathey; Denise M Scholtens; Richard E Heinz; Rick Lowe; Yvonne B Feeney; Oukseub Lee; Thomas E Kmiecik; Judith A Wolfman; Charles V Clevenger; Peter H Gann; Susan Gapstur; Robert T Chatterton; Seema A Khan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-18       Impact factor: 4.254

10.  Epithelial membrane antigen expression in breast fluids and 'witch's milk'.

Authors:  C J Williams; A S Dion; J Carten; G C Buehring
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.